<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) February 20, 1997
---------------------
EuroMed, Inc.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Nevada 0-27720 88-031770
-------------- ------------ -------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation File Number) Identification No.)
Wilhelminakanaal Noord 6, NL 4902VR Oosterhout, The Netherlands
- --------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code 011-31-16-203-7440
-----------------------------
<PAGE> 2
ITEM 4. CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT.
On February 20, 1997, EuroMed, Inc. ("EuroMed") engaged Killman,
Murrell and Company, P.C. ("Killman") as its independent public accountant.
Prior to engaging Killman, EuroMed discussed with Killman the reason given by
EuroMed's former accountant, KPMG Accountants N.V. ("KPMG"), for its
resignation. KPMG believed that the internal control structure at EuroMed at
the time KPMG resigned was not adequate to develop reliable financial
statements. Killman has told EuroMed that it believes EuroMed has resolved the
problems that led to KPMG's resignation. EuroMed has provided Killman with the
above disclosures prior to filing this Form 8-K with the Commission and will
file Killman's response, if any, as an Exhibit to an amendment to this Form 8-K
as required.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(c) Exhibits
None.
2
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
EUROMED, INC.
Date: February 25, 1997 By: /s/ Robert A. Shuey, III
----------------------------
Robert A. Shuey, III
Chief Executive Officer
3
